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 Abstract 
  Background/Aims:   Osteopontin (OPN) has been implicated in the pathology of several renal 
conditions. The aim of this study was to clarify the roles of OPN in diabetic nephropathy.   Meth-
ods:   Diabetes mellitus (DM) was induced in wild-type (WT) and OPN knockout (KO) mice by in-
jecting streptozotocin. The mice were killed 20 weeks after induction of DM and their kidneys 
removed.   Results:   Renal mRNA expression of OPN was increased in WT-DM mice compared to 
WT-sham mice. Immunohistochemistry showed high levels of OPN expression in the proximal 
tubules of WT-DM mice. Kidney weight and urinary albumin excretion increased to similar levels 
in the WT-DM and KO-DM mice. Interstitial fibrosis was increased in WT-DM mice compared to 
KO-DM mice. However, there were no differences in the degree of mesangial expansion or glo-
merular hypertrophy between the two groups. F4/80-positive cells (macrophages) and FSP-1-
positive cells (fibroblasts) showed significantly higher infiltration in WT-DM mice than in KO-DM 
mice. Renal mRNA expression of NADPH oxidase subunits and urinary 8-isoprostane excretion 
were also increased in WT-DM mice.  Conclusions:  These results indicated that OPN is a key mol-
ecule that induces interstitial fibrosis in the diabetic kidney, but does not induce glomerular 
sclerosis.    Copyright © 2012 S. Karger AG, Basel 
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 Introduction 
  Chronic kidney disease (CKD) is constituted predominantly by diabetes mellitus (DM) 
nephropathy, the pathological profile of which includes glomerulosclerosis, tubular atrophy, 
and interstitial fibrosis. Of these pathological changes, the tubulointerstitial component is 
most closely correlated with the progression of renal failure   [1]  .
    A number of cytokine systems including transforming growth factor-     (TGF-  )  1   [2] , 
angiotensin II   [3]  , and osteopontin (OPN) have been implicated in tubulointerstitial injury. 
Microarray analyses identified OPN as one of the major genes upregulated in DM nephrop-
athy   [4]  . OPN is a glycosylated phosphoprotein that contains an arginine-glycine-aspartate 
(RGD)-binding sequence that enables interaction with various integrins and CD44. OPN is 
produced by osteoblasts, macrophages, endothelial cells, and epithelial cells and acts by fa-
cilitating cell adhesion and migration   [5]  . In the normal kidney, OPN is expressed mainly in 
the loop of Henle and distal nephron. OPN expression has been shown to be upregulated in 
renal tubular cells and glomeruli in glomerulonephritis, hypertension, and ischemic acute 
renal failure   [5]  .
  Recently, it was reported that quantification of OPN immunostaining revealed a marked 
increase in the percentage of OPN-positive proximal tubular cells in human DM kidneys, 
which correlated strongly with the degree of cortical scarring  [6] . This finding indicates that 
OPN expression may play a key role in the interstitial fibrosis associated with DM nephrop-
athy.
    The present study investigated the role of OPN in the pathogenesis of DM nephropathy. 
DM was induced in wild-type (WT) and OPN knockout (KO) mice by repeated intraperito-
neal injections of streptozotocin (STZ). Interstitial fibrosis was increased in the WT-DM 
mice compared to the KO-DM mice. However, there were no differences in mesangial expan-
sion and glomerular hypertrophy between the two groups. The data presented here suggest 
that increased expression of OPN in the DM kidney has a deleterious effect by increasing 
renal interstitial fibrosis, but not glomerular sclerosis.
  Materials  and  Methods 
 Animals 
  KO mice were generated as described previously   [7]  . Eight-week-old male KO mice (n = 
11) and age-matched male C57BL/6 WT mice (n = 12) were used. All the mice were housed 
in a room with a 12-hour light/dark cycle, with the room temperature maintained at 24    °   C. 
The experimental protocol was approved by the Animal Studies Committee of Ehime Uni-
versity. DM was induced by intraperitoneal injections of STZ (50 mg/kg in citrate buffer, pH 
4.2) for 5 days. Mice injected with the same volume of citrate buffer acted as sham controls. 
The mice had unlimited access to water and standard mouse chow. Plasma glucose levels 
were measured 7 days and every 4 weeks after the STZ injections. Animals with a plasma 
glucose level   1  250 mg/dl at day 7 were considered diabetic and used for the 20-week experi-
ments. Measurements of systolic blood pressure were performed using the indirect tail-cuff 
method (MK-2000; Muromachi Kikai, Tokyo, Japan). Twenty-four-hour urine samples were 
collected in metabolic cages. At the end of the study, blood samples were obtained from the 
inferior vena cava and the kidneys were then removed and weighed. Coronal sections of the 
kidneys were fixed in 10% formalin and then embedded in paraffin for histological evalua-
tion. The remainder of the kidney was snap-frozen in liquid nitrogen for mRNA or immu-
nohistochemical analysis.89
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  Biochemical  Measurements 
 Urine albumin concentration was measured by an enzyme-linked immunosorbent assay 
(ELISA) commercial kit (EXOCELL, Philadelphia, Pa., USA) and serum creatinine by an au-
tomatic analyzer (Nagahama LSL, Shiga, Japan). Plasma OPN and urinary 8-isoprostane 
were also measured using commercially available ELISA kits (IBL, Gunma, Japan, and De-
troit R&D, Inc., Detroit, Mich., USA, respectively).
    Morphologic Analysis and Immunohistochemistry 
  The kidney sections were stained with Periodic Acid-Schiff (PAS) and Masson’s tri-
chrome method. Cross sections of the PAS and Masson’s trichrome stains were semi-quan-
tified using NIH ImageJ software (http://rsb.info.nih.gov/ij/). Glomerular volume and mes-
angial area were quantified by scanning 10 non-overlapping glomeruli of each kidney sec-
tion stained by PAS. The fibrotic blue staining areas by Masson’s trichrome stains were also 
quantified by scanning 10 non-overlapping fields of each kidney section. Each positive area 
(glomerular volume, mesangial area, and interstitial fibrosis) was expressed as a percentage 
of the total area.
    Immunohistochemistry was performed using Simple stain kits (Nichirei, Tokyo, Ja-
pan) according to the manufacturer’s instructions. Briefly, paraffin-embedded sections 
were deparaffinized with xylene and then rehydrated in a descending series of ethanol. The 
sections were treated for 15 min with 3% H  2 O 2   in methanol to inactive endogenous per-
oxidase and then incubated at room temperature for 1 h with primary antibodies against 
either rabbit anti-OPN (1:     50; IBL), rat anti-F4/80 (1:     500; BMA, Augst, Switzerland), anti-
FSP-1 (1:     100; Thermo, Miami, Fla., USA),    -SMA  (1:    100; Abcam, Cambridge, UK), anti-
TGF-     (1:    50; Abcam) or anti-type IV collagen (1:     500; Abcam). These positive stains with 
diaminobenzidine were quantified using ImageJ software by scanning 6 non-overlapping 
fields in each kidney section, and expressing the positive area as a percentage of the total 
area.
    RNA Isolation and Real-Time PCR 
  Total RNA was isolated from the cortex of the kidney using ISOGEN (Nippon gene, To-
kyo, Japan) according to the manufacturer’s protocol. Gene expression was analyzed quan-
titatively by real-time RT-PCR using fluorescent SYBR Green technology (LightCycler; 
Roche Molecular Biochemicals).     -Actin cDNA was amplified and quantitated in each 
cDNA preparation in order to normalize the relative amounts of the target genes. The prim-
er sequences were listed in the online supplementary table (for all online suppl. material, see 
www.karger.com/doi/10.1159/000337330).
  Protein  Analysis 
  Western blotting analysis was performed as described previously   [8]  . The lysates were 
separated on 10% polyacrylamide gels, followed by immunoblotting using rabbit anti-OPN 
(IBL).     -Actin (Cell Signaling Technology, Beverly, Mass., USA) was used to normalize the 
protein loaded on the blots. This analysis was carried out independently three times.
  Statistical  Analysis 
  Data are expressed as mean   8   SEM. For multiple comparisons, statistical analysis was 
performed by 2-way ANOVA and Scheffe’s post-hoc test. The Mann-Whitney U test was used 
for comparisons between the two groups. p values   !  0.05 were considered statistically sig-
nificant.90
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  R e s u l t s  
  DM and Increased OPN Expression 
 Plasma glucose levels were increased in the WT-DM and KO-DM mice 60 days after STZ 
administration, with no significant difference between the two groups of mice (WT-DM 591 
  8   19 mg/dl; KO-DM 577   8   26 mg/dl;   fig. 1  ). Renal OPN gene and protein expression were 
evaluated by real-time PCR and Western blot analysis. The expression of OPN mRNA was 
significantly higher in WT-DM mice than in WT-sham mice (WT-DM 3.80   8   1.1-fold; 
  fig. 2  a). The expression of OPN protein was increased by the induction of DM (  fig. 2  b). Im-
munohistochemical analysis showed that OPN protein was localized mainly in the medul-
lary tubules in WT-sham mice and was upregulated markedly in the proximal tubules of 
WT-DM mice (  fig. 2  c). Plasma OPN tended to be increased in the WT-DM mice compared 
to the WT-sham mice, although this difference was not statistically significant (WT-sham 
4,670   8   532.4 ng/ml; WT-DM 6,552   8   763.6 ng/ml;   table 1  ).
  B i o l o g i c a l   P a r a m e t e r s  
  The physiological and biochemical data are presented in   table 1  . In the DM mice, body 
weight was decreased and kidney weight was increased compared to values in sham mice. 
Blood pressure at 20 weeks did not differ between the four groups. Urine albumin excretion 
was increased by the induction of DM, with similar levels in the WT-DM and KO-DM mice.
  Fig. 1.   Blood glucose levels were 
measured in DM and sham mice 
(WT-sham, n = 5; WT-DM, n = 7; 
KO-sham, n = 5; KO-DM, n = 7). 
  *  p   !   0.05 vs. WT-sham mice. 
Table 1.   Physiological and biological parameters in the four groups of mice
WT-sham
(n = 5)
WT-DM
(n = 7)
KO-sham
(n = 5)
KO-DM
(n = 6)
Body weight, g 33.081.8 24.680.5* 36.481.5 25.580.9*
Kidney weight, mg 218810 293812* 221811 293818*
Blood pressure, mm Hg 11987 11582 11187 11487
Creatinine, mg/dl 0.0680.05 0.1080.08* 0.0680.04 0.0780.04
Urine albumin, g/day 40.286.5 163.2819.8* 18.185.2 211.0849.4*
Plasma OPN, ng/ml 4,6708532 6,5528763
V  alues are mean 8 SEM. * p < 0.05 vs. WT-sham and KO-sham mice.91
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  G l o m e r u l a r   I n j u r y  
 In the PAS stains ( fig. 3 a–e), we found the same degree of glomerular hypertrophy (WT-
sham 1.0  8  0.02; WT-DM 1.3  8  0.03; KO-sham 1.2  8  0.04; KO-DM 1.4  8  0.04;  fig. 3 e) and 
mesangial matrix expansion (WT-sham 22.2   8   1.4%; WT-DM 38.0   8   2.5%; KO-sham 24.9 
  8   1.0%; KO-DM 33.3   8   2.5%;   fig. 3  f) in the WT-DM and KO-DM mice. Immunohisto-
chemical analysis showed that there were no significant differences of type IV collagen-pos-
itive areas among the four groups (WT-sham 20.0   8   1.5%; WT-DM 28.6   8   2.1%; KO-sham 
22.0   8   4.6%; KO-DM 27.5   8   1.2%;   fig. 3 g–k).
  Renal  Interstitial  Fibrosis 
  Interstitial fibrosis was increased significantly in WT-DM mice, as shown by Masson’s 
trichrome staining. However, importantly, interstitial fibrosis was diminished in KO-DM 
mice (WT-sham 4.5   8   0.5%; WT-DM 12.1   8   1.0%; KO-sham 3.6   8   0.3%; KO-DM 6.5   8  
0.4%;   fig. 4 ).
    Macrophage Infiltration and Fibroblast Accumulation 
  F4/80-positive cells were observed only rarely in WT-sham and KO-sham mice. In con-
trast, the number of these cells was increased significantly in interstitial lesions in WT-DM 
mice, but not in KO-DM mice (WT-sham 0.11   8   0.03%; WT-DM 1.05   8   0.03%; KO-sham 
0.10   8   0.04%; KO-DM 0.22   8   0.04%;   fig. 5  ). FSP-1-positive cells were observed rarely in 
  Fig. 2.   Renal mRNA (  a  ) and protein levels of OPN (  b  ). RNA was isolated from the kidney for quantitative 
RT-PCR (WT-sham, n = 5; WT-DM, n = 7). Whole protein was isolated from the kidney for Western blot-
ting (WT-sham, n = 5; WT-DM, n = 7). Values are expressed as mean  8  SEM.  *  p  !  0.05.   c  Representative 
images of immunohistochemistry of OPN protein in WT-sham and WT-DM mice. 92
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WT-sham or KO-sham mice, whereas these cells were increased significantly in interstitial 
legions of WT-DM mice, but not in KO-DM mice (WT-sham 0.11  8  0.02%; WT-DM 0.77  8  
0.03%; KO-sham 0.18  8  0.04%; KO-DM 0.28  8  0.04%;  fig. 6 a–e).   -SMA-positive cells were 
also observed rarely in interstitial lesions in WT-sham or KO-sham mice, whereas these cells 
were increased significantly in interstitial legions and tubules of WT-DM mice, but not in 
KO-DM mice (WT-sham 1.7   8   0.5%; WT-DM 7.3   8   1.0%; KO-sham 1.4   8   0.6%; KO-DM 
2.6  8  0.7%;  fig. 6 f–j). These data indicated that OPN knockout attenuated DM-induced mac-
rophage recruitment and fibroblast cell proliferation to the kidney.
  Fig. 3a–f   For legend see next page. 93
Nephron Extra 2012;2:87–103
 DOI:  10.1159/000337330 
  Published online: March 29, 2012 
EXTRA
  Nagao et al.: Osteopontin and Diabetic Nephropathy 
www.karger.com/nne
  © 2012 S. Karger AG, Basel 
    Expression of Fibrosis-Related Genes and TGF-    
  In both WT-DM and KO-DM mice, DM induction increased renal mRNA expression 
of type IV collagen (WT-sham 1.00   8   0.07-fold; WT-DM 1.43   8   0.05-fold; KO-sham 0.81 
  8   0.12-fold; KO-DM 1.28   8   0.06-fold;   fig. 7  c), fibronectin (WT-sham 1.00   8   0.23-fold; 
WT-DM 3.56   8   0.43-fold; KO-sham 0.87   8   0.05-fold; KO-DM 2.95   8   0.43-fold;   fig. 7 d) 
and TGF-     (WT-sham 1.0   8   0.08-fold; WT-DM 1.51   8   0.11-fold; KO-sham 0.79   8   0.15-
fold; KO-DM 1.35   8   0.06-fold;   fig. 7  e). However, type I collagen (WT-sham 1.00   8   0.10-
fold; WT-DM 3.43   8   0.71-fold; KO-sham 0.57   8   0.06-fold; KO-DM 1.28   8   0.15-fold; 
 fig. 7 a) and type III collagen mRNA (WT-sham 1.00  8  0.22-fold; WT-DM 3.47  8  0.71-fold; 
  Fig. 3.  Representative micrographs of glomeruli (pe-
riodic acid-Schiff staining) in WT-sham (  a ),  WT-
DM (  b  ), KO-sham (  c  ), and KO-DM mice (  d ).  Glo-
merular volume (  e  ) and mesangial area (  f  ) of WT-
sham, WT-DM, KO-sham, and KO-DM mice 
(WT-sham, n = 5; WT-DM, n = 7; KO-sham, n = 5; 
KO-DM, n = 7).   *  p   !   0.05. Representative images of 
immunohistochemistry of type IV collagen protein 
in WT-sham ( g ), WT-DM ( h ), KO-sham ( i ), and KO-
DM mice (  j  ) .   k   Type IV collagen staining area of 
WT-sham, WT-DM, KO-sham, and KO-DM mice 
(WT-sham, n = 5; WT-DM, n = 7; KO-sham, n = 5; 
KO-DM, n = 7). 94
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KO-sham 0.68   8   0.10-fold; KO-DM 1.28   8   0.21-fold;   fig. 7  b) were increased in WT-DM 
mice, but not in KO-DM mice. Immunohistochemical analysis also showed that TGF-    
protein expression in tubules was increased to the same level in WT-DM and KO-DM mice 
(WT-sham 2.3   8   0.7%; WT-DM 10.4   8   1.7%; KO-sham 2.2   8   0.7%; KO-DM 8.9   8   1.7%; 
 fig. 7 f–j).
    The Role of Oxidative Stress 
  To determine whether OPN knockout alters DM-induced oxidative stress, we measured 
expression of NADPH oxidase subunits mRNA including p47  phox   and gp91  phox   by real-time 
  Fig. 4.   Representative micrographs of Masson’s tri-
chrome-stained renal sections in WT-sham (  a ), 
WT-DM (  b  ), KO-sham (  c  ), and KO-DM mice (  d ). 
  e  Bar graph showing semi-quantified renal fibrosis 
areas (%) (WT-sham, n = 5; WT-DM, n = 7; KO-
sham, n = 5; KO-DM, n = 7). Values are expressed 
as mean   8   SEM.   *  p   !   0.05. 95
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PCR. We found that expression of p47  phox  (WT-sham 1.00  8  0.09-fold; WT-DM 2.32  8  0.21-
fold; KO-sham 0.92   8   0.10-fold; KO-DM 1.50   8   0.13-fold;   fig. 8 a)  and  gp91 phox   (WT-sham 
1.00   8   0.07-fold; WT-DM 1.91   8   0.11-fold; KO-sham 1.03   8   0.08-fold; KO-DM 1.51   8  
0.09-fold;   fig. 8  b) was upregulated in WT-DM mice. Deficiency of OPN attenuated these in-
creases in NADPH oxidase subunit genes. To further evaluate the effect of OPN on renal 
oxidative stress, we measured urinary levels of 8-isoprostane and demonstrated a marked 
increase in 8-isoprostane excretion in WT-DM mice. In contrast, this increase was reduced 
significantly by OPN knockout (WT-sham 0.52  8  0.09 ng/day; WT-DM 5.04  8  0.80 ng/day; 
KO-sham 0.28   8   0.07 ng/day; KO-DM 2.07   8   0.45 ng/day;   fig. 8  c).
  Fig. 5.   Representative images of F4/80 (macro-
phage) in WT-sham (  a  ), WT-DM (  b  ), KO-sham (  c ), 
and KO-DM mice (  d ).   e   Bar graph showing F4/80-
positive areas (%) (WT-sham, n = 5; WT-DM, n = 
7; KO-sham, n = 5; KO-DM, n = 7). Values are ex-
pressed as mean   8   SEM.   *  p   !   0.05. 96
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    M1 and M2 Macrophage-Associated mRNA Expression 
  Renal mRNA expression of M1 (CD11c, TLR4, TNF-    , and MCP-1) and M2 (CD163, 
mannose receptor, MGL-2, and IL-10) macrophage-associated markers was analyzed. Of the 
M1 macrophage markers, CD11c (WT-sham 1.00   8   0.10-fold, WT-DM 1.88   8   0.22-fold; on-
line suppl. fig. A), TLR4 (WT-sham 1.00  8  0.10-fold; WT-DM 1.82  8  0.08-fold; online suppl. 
fig. B), and MCP-1 (WT-sham 1.00   8   0.13-fold; WT-DM 5.02   8   0.23-fold; online suppl. fig. 
D) were increased significantly in WT-DM mice compared to sham mice. Similarly, expres-
sion of the M2 macrophage markers CD163 (WT-sham 1.00   8   0.08-fold; WT-DM 6.16   8  
0.51-fold; online suppl. fig. E), mannose receptor (WT-sham 1.00   8   0.05-fold; WT-DM 4.76 
  Fig. 6a–e   For legend see next page. 97
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  8  0.44-fold; online suppl. fig. F) and MGL-2 (WT-sham 1.0  8  004-fold; WT-DM 3.8  8  0.71-
fold; online suppl. fig. G) was significantly higher in the WT-DM mice than in the sham mice.
  Our investigation also showed that KO-DM mice had reduced expression of the M1 mac-
rophage markers CD11c (KO-sham 1.05   8   0.09-fold; K O-DM 1 .34   8   0.10-fold; online 
suppl. fig. A) and MCP-1 (KO-sham 0.47   8   0.09-fold; KO-DM 3.37   8   0.03-fold; online 
suppl. fig. D) and the M2 macrophage markers CD163 (KO-sham 0.64   8   0.06-fold; KO-DM 
2.57   8   0.44-fold; online suppl. fig. E), mannose receptor (KO-sham 0.80   8   0.07-fold; KO-
DM 3.10   8   0.32-fold; online suppl. fig. F) and MGL-2 (KO-sham 0.67   8   0.03-fold; KO-DM 
1.55   8   0.18-fold; online suppl. fig. G).
  Fig. 6.   Representative images of FSP-1 (fibroblast) 
in WT-sham (  a  ), WT-DM (  b  ), KO-sham (  c ),  and 
KO-DM mice (  d ).   e   Bar graph showing FSP-1-pos-
itive areas (%) (WT-sham, n = 5; WT-DM, n = 7; 
KO-sham, n = 5; KO-DM, n = 7). Values are ex-
pressed as mean  8  SEM.  *  p  !  0.05. Representative 
images of     -SMA in WT-sham (  f  ), WT-DM (  g ), 
KO-sham (  h  ), and KO-DM mice (  i ).   j   Bar graph 
showing     -SMA staining areas (%) (WT-sham, n = 
5; WT-DM, n = 7; KO-sham, n = 5; KO-DM, n = 7). 
Values are expressed as mean   8   SEM.   *  p   !   0.05. 98
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  Discussion 
 Tubulointerstitial fibrosis is important in the progression of renal damage  [9] , and it has 
been shown in mice that OPN deficiency attenuates renal tubulointerstitial fibrosis caused 
by either ischemia/reperfusion injury  [10] , unilateral ureteral obstruction  [11]  or angiotensin 
II   [12] .
    It has been shown in a mouse model of DM that OPN deficiency attenuates mesangial 
matrix expansion and urine albumin excretion   [13, 14]  , although there are no reports as to 
whether or not OPN plays a critical role in interstitial fibrosis. To clarify this issue, we used 
OPN knockout mice and induced DM by infusion of STZ.
    The major findings of this study were that OPN expression was increased mainly in 
proximal renal tubules after induction of DM, and that DM induced severe interstitial fibro-
sis, macrophage infiltration, fibroblast accumulation, and expression of genes related to fi-
brosis (type I, III collagen) and oxidative stress (p47  phox , gp91  phox ). We also demonstrated that 
these changes were attenuated by OPN knockout.
  Fig. 7a–e   For legend see next page. 99
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    OPN has been reported to be directly or indirectly related to the pathogenesis of DM 
target organ damage including nephropathy. High glucose induces OPN expression in renal 
fibroblasts   [15]  , vascular smooth muscle cells   [16]  , monocytes   [17]  , and mesangial cells   [18]  . 
There is also evidence that patients with DM have higher concentrations of plasma OPN than 
non-DM controls   [19]  . Lorenzen et al.   [13]   reported that OPN knockout protected against 
albuminuria and mesangial expansion in DM mice, while Nicholas et al.   [14]   showed that 
diabetes induced by STZ was associated with albuminuria and mesangial expansion and that 
OPN knockout attenuated these abnormal changes. However, in the present study, we showed 
that OPN knockout reduced interstitial fibrosis, but not mesangial expansion or albumin-
uria. Furthermore, there was no difference in type IV collagen expression in the mesangium 
  Fig. 7.  Real-time PCR for type I collagen ( a ), type III 
collagen (  b  ), type IV collagen (  c  ), fibronectin (  d ), 
and TGF-     ( e  ). WT-sham, n = 5; WT-DM, n = 7; 
KO-sham, n = 5; KO-DM, n = 7. Values are ex-
pressed as mean   8   SEM.   *  p   !   0.05. Representative 
images of immunohistochemistry of TGF-     pro-
tein in WT-sham (  f  ), WT-DM (  g  ), KO-sham (  h ), 
and KO-DM mice (  i ).   j   Bar graph showing TGF-    
staining areas (%) (WT-sham, n = 5; WT-DM, n = 7; 
KO-sham, n = 5; KO-DM, n = 7). Values are ex-
pressed as mean   8   SEM.   *  p   !   0.05. 100
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between WT-DM and KO-DM mice. In their study, Nicholas et al.   [14]   reported increased 
glomerular OPN mRNA expression; however, in our study we did not demonstrate OPN ex-
pression in the mesangium using immunohistochemistry. The reason for this difference is 
not clear but may be due to the different mouse strains used for OPN knockout or the pro-
cedure of diabetes induction. 
    It has been reported that macrophages play an important role in tubulointerstitial in-
jury in DM nephropathy   [20]  . Macrophages contribute to fibroblast proliferation   [21]   and 
produce matrix protein such as type I collagen   [22]  . Macrophages also produce OPN inde-
pendently, which in turn stimulates production of MCP-1, resulting in macrophage accumu-
lation   [23]  . The present study showed that OPN deficiency attenuated macrophage recruit-
ment to the kidney, indicating that OPN is a major macrophage chemoattractant that acts 
either directly or indirectly in DM nephropathy.
    Two subtypes of macrophages exist in tissues   [24]  , M1 macrophages and M2 macro-
phages. M1 macrophages express high levels of proinflammatory cytokines and enhance tis-
sue inflammatory responses, while M2 macrophages express high levels of anti-inflamma-
tory cytokines such as IL-10 and promote tissue repair and enhance fibrogenesis of fibro-
blasts  [25] . Recently, it was reported that expression of M1 and M2 macrophage marker genes 
was elevated in the renal cortex of DM model mice, and that both M1 and M2 macrophages 
participated in the development of DM nephropathy  [26] . To determine which types of mac-
rophages are influenced by OPN, we compared the expression of M1 and M2 macrophage 
markers using real-time RT-PCR analyses. M1 macrophage markers including CD11c   [26, 
32]  , TLR4   [32]  , and MCP1   [26]  , and the M2 macrophage markers CD163   [32]  , mannose re-
ceptor   [26, 32]  , and MGL-2   [26]   were elevated in WT-DM mice kidney, whereas OPN defi-
  Fig. 8.   Real-time PCR for p47  phox   ( a  ) and gp91  phox   ( b ).   c   Bar graph showing urinary 8-isoprostane excre-
tion measured by ELISA (WT-sham, n = 5; WT-DM, n = 7; KO-sham, n = 5; KO-DM, n = 7). Values are 
expressed as mean   8   SEM.   *  p   !   0.05. 101
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ciency attenuated DM-induced expression of M1 (CD11c and MCP-1) and M2 macrophage 
(CD163, mannose receptor, and MGL-2) markers. These results indicate that OPN induces 
not only M1 macrophages, but also M2 macrophages in STZ-induced DM nephropathy.
    Increased production of reactive oxygen species (ROS) may contribute to diabetic ne-
phropathy, with an important source of ROS production being nicotinamide adenine dinu-
cleotide phosphate (NADPH) oxidase. It has been reported that the kidneys of rats with DM 
have increased expression of NADPH oxidase (p47  phox   and gp91  phox  )   [27, 28]  . In our study, 
OPN knockout caused significant decreases in the expression levels of p47  phox   and gp91  phox . 
Urinary 8-isoprostane excretion, a marker of oxidative stress, also showed a marked increase 
in WT-DM mice, with this increase being reduced significantly by OPN knockout. These 
results indicated that OPN acts as a proinflammatory factor that regulates oxidative stress 
in the kidney.
    Recently, we reported that aldosterone upregulated expression of OPN in renal fibro-
blasts and that OPN-siRNA completely blocked aldosterone-induced collagen synthesis and 
fibroblast cell proliferation   [29]  . We also reported recently that high glucose levels upregu-
lated collagen synthesis and OPN expression in renal fibroblasts   [15]  . In the present study, 
DM (high glucose) induced fibroblast accumulation and expression of fibrosis-related genes 
such as type I and type III collagen, and that these changes were attenuated significantly by 
OPN knockdown. Taken together, these findings indicate that OPN may contribute directly 
to the pathogenesis of interstitial fibrosis of DM nephropathy by inducing collagen synthesis 
and renal fibroblast proliferation.
  T G F -     is a key player in the accumulation of extracellular matrix and is a well-estab-
lished inducer of epithelial mesenchymal transition (EMT)   [30]  . In the present study, DM 
induced similar levels of TGF-     expression in both the WT and KO mice in tubular epithe-
lial cells. However, interstitial fibrosis was suppressed in KO-DM mice indicating that OPN 
is not a mediator of TGF-    . Hsieh et al.   [31]   showed that TGF-     antisense inhibited high 
glucose-induced OPN expression in immortalized renal proximal tubular cells, indicating 
that TGF-     is one of the mediators of OPN. However, further study is needed to confirm 
these associations.
  The present study showed that OPN deficiency protected against increases in serum cre-
atinine level resulting from induction of DM, as occurs in WT-DM mice. However, there 
were no differences in the level of urine albumin excretion and mesangial expansion and 
glomerular hypertrophy between WT-DM and KO-DM mice, indicating that protection of 
renal function in KO-DM mice may be due to inhibition of tubulointerstitial fibrosis induced 
by high glucose (DM).
    In conclusion, OPN is a promoter of DM-induced inflammation, oxidative stress, and 
interstitial fibrosis in the kidney. Inhibition of OPN may provide a potential target for ther-
apeutic intervention aimed at preventing progression of kidney damage induced by DM.
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